N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions

References

• Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333–1341.
   PubMed Web of Science ®Google Scholar
• Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents. 2005;25:11–25.
   PubMed Web of Science ®Google Scholar
• Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6:589–601.
   PubMed Web of Science ®Google Scholar
• Holmes KK. Toxicity of colistin and polymyxin B. N Engl J Med. 1964;271:633–634.
   PubMed Web of Science ®Google Scholar
• Horton J, Pankey GA. Polymyxin B, colistin, and sodium colistimethate. Med Clin North Am. 1982;66:135–142.
   PubMed Web of Science ®Google Scholar
• Koch-Weser J, Sidel VW, Federman EB, et al. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 1970;72:857–868.
   PubMedGoogle Scholar
• Nord NM, Hoeprich PD. Polymyxin B and colistin. A critical comparison. N Engl J Med. 1964;270:1030–1035.
   PubMed Web of Science ®Google Scholar
• Hartzell JD, Neff R, Ake J, et al. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis. 2009;48:1724–1728.
   PubMed Web of Science ®Google Scholar
• Pogue JM, Lee J, Marchaim D, et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011;53:879–884.
   PubMed Web of Science ®Google Scholar
• Kubin CJ, Ellman TM, Phadke V, et al. Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. J Infect. 2012;65:80–87.
   PubMed Web of Science ®Google Scholar
• Deryke CA, Crawford AJ, Uddin N, et al. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrob Agents Chemother. 2010;54:4503–4505.
   PubMed Web of Science ®Google Scholar
• Mostardeiro MM, Pereira CAP, Marra AR, et al. Nephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patients. Antimicrob Agents Chemother. 2013;57:1442–1446.
   PubMed Web of Science ®Google Scholar
• Garonzik SM, Li J, Thamlikitkul V, et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother. 2011;55:3284–3294.
   PubMed Web of Science ®Google Scholar
• Bergen PJ, Bulitta JB, Forrest A, et al. Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model. Antimicrob Agents Chemother. 2010;54:3783–3789.
   PubMed Web of Science ®Google Scholar
• Dudhani RV, Turnidge JD, Nation RL, et al. fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. J Antimicrob Chemother. 2010;65:1984–1990.
   PubMed Web of Science ®Google Scholar
• Antoniadou A, Kontopidou F, Poulakou G, et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother. 2007;59:786–790.
   PubMed Web of Science ®Google Scholar
• Beno P, Krcmery V, Demitrovicova A. Bacteraemia in cancer patients caused by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin. Clin Microbiol Infect. 2006;12:497–498.
   PubMed Web of Science ®Google Scholar
• Yousef JM, Chen G, Hill PA, et al. Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J Antimicrob Chemother. 2012;67:452–459.
   PubMed Web of Science ®Google Scholar
• Ozkan G, Ulusoy S, Orem A, et al. How does colistin-induced nephropathy develop and can it be treated? Antimicrob Agents Chemother. 2013;57:3463–3469.
   PubMed Web of Science ®Google Scholar
• Ghlissi Z, Hakim A, Mnif H, et al. Evaluation of colistin nephrotoxicity administered at different doses in the rat model. Ren Fail. 2013;35:1130–1135.
   PubMed Web of Science ®Google Scholar
• Ozyilmaz E, Ebinc FA, Derici U, et al. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? Intensive Care Med. 2011;37:141–146.
   PubMed Web of Science ®Google Scholar
• Dai C, Li J, Tang S, et al. Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. Antimicrob Agents Chemother. 2014;58:4075–4085.
   PubMed Web of Science ®Google Scholar
• Liu Y, Dai C, Gao R, et al. Ascorbic acid protects against colistin sulfate-induced neurotoxicity in PC12 cells. Toxicol Mech Methods. 2013;23:584–590.
   PubMed Web of Science ®Google Scholar
• Dai C, Ciccotosto GD, Cappai R, et al. Curcumin attenuates colistin-induced neurotoxicity in N2a cells via anti-inflammatory activity, suppression of oxidative stress, and apoptosis. Mol Neurobiol. 2016;55:421–434.
   PubMed Web of Science ®Google Scholar
• Dai C, Tang S, Velkov T, et al. Colistin-induced apoptosis of neuroblastoma-2a cells involves the generation of reactive oxygen species, mitochondrial dysfunction, and autophagy. Mol Neurobiol. 2016;53:4685–4700.
   PubMed Web of Science ®Google Scholar
• Dai C, Tang S, Deng S, et al. Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2/HO-1 pathway. Antimicrob Agents Chemother. 2015;59:579–585.
   PubMed Web of Science ®Google Scholar
• Yousef JM, Chen G, Hill PA, et al. Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob Agents Chemother. 2011;55:4044–4049.
   PubMed Web of Science ®Google Scholar
• Tylicki L, Rutkowski B, Hörl WH. Antioxidants: a possible role in kidney protection. Kidney Blood Press Res. 2003;26:303–314.
   PubMed Web of Science ®Google Scholar
• Luo J, Tsuji T, Yasuda H, et al. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant. 2008;23:2198–2205.
   PubMed Web of Science ®Google Scholar
• Efrati S, Averbukh M, Berman S, et al. N-Acetylcysteine ameliorates lithium-induced renal failure in rats. Nephrol Dial Transplant. 2005;20:65–70.
   PubMed Web of Science ®Google Scholar
• Chen N, Aleksa K, Woodland C, et al. N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats. Br J Pharmacol. 2009;153:1364–1372.
   Web of Science ®Google Scholar
• Ocak S, Gorur S, Hakverdi S, et al. Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats. Basic Clin Pharmacol Toxicol. 2007;100:328–333.
   PubMed Web of Science ®Google Scholar
• Borisenok OA, Bushma MI, Baraban OV, et al. [Therapeutic effect of acetylcysteine on rats with gentamicin-induced nephropathy]. Eksp Klin Farmakol. 2012;75:10–13.
   PubMedGoogle Scholar
• Odabasi Z, Karaalp A, Cermik H, et al. Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine. Antimicrob Agents Chemother. 2009;53:3100–3102.
   PubMed Web of Science ®Google Scholar
• Parks WC, Wilson CL, López-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004;4:617–629.
   PubMed Web of Science ®Google Scholar
• DrugBank [Internet]. Canada: OMx Personal Health Analytics Inc; [Cited 2018 Apr 2]. Available from: http://www.drugbank.ca
   Google Scholar
• Horak E, Hopfer SM, Sunderman FW. Jr. Spectrophotometric assay for urinary N-acetyl-beta-D-glucosaminidase activity. Clin Chem. 1981;27:1180–1185.
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–119.
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–1111.
   PubMed Web of Science ®Google Scholar
• Hakim A, Kallel H, Sahnoun Z, et al. Lack of nephrotoxicity following 15-days therapy with high doses of colistin in rats. Med Sci Monit. 2008;14:74–77.
   Web of Science ®Google Scholar
• El-Sisi AE-DE, El-Syaad ME, El-Desoky KI, et al. Protective effects of alpha lipoic acid versus N-acetylcysteine on ifosfamide-induced nephrotoxicity. Toxicol Ind Health. 2015;31:97–107.
   PubMed Web of Science ®Google Scholar
• Abdelrahman AM, Al Salam S, AlMahruqi AS, et al. N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity. J Appl Toxicol. 2010;30:15–21.
   PubMed Web of Science ®Google Scholar
• Ali BH, Al-Salam S, Al-Husseini I, et al. Comparative protective effect of N-acetyl cysteine and tetramethylpyrazine in rats with gentamicin nephrotoxicity. J Appl Toxicol. 2009;29:302–307.
   PubMed Web of Science ®Google Scholar
• Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2:1097–1100.
   PubMed Web of Science ®Google Scholar
• Amorati R, Valgimigli L. Advantages and limitations of common testing methods for antioxidants. Free Radic Res. 2015;49:633–649.
   PubMed Web of Science ®Google Scholar
• Palmieri B, Sblendorio V. Oxidative stress tests: overview on reliability and use. Eur Rev Med Pharmacol Sci. 2007;11:309–342.
   PubMed Web of Science ®Google Scholar
• Young IS. Measurement of total antioxidant capacity. J Clin Pathol. 2001;54:339.
   PubMed Web of Science ®Google Scholar
• Briguori C, Quintavalle C, De Micco F, et al. Nephrotoxicity of contrast media and protective effects of acetylcysteine. Arch Toxicol. 2011;85:165–173.
   PubMed Web of Science ®Google Scholar
• Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33:829–837.
   PubMed Web of Science ®Google Scholar
• Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxidants Redox Signaling. 2011;15:1583–1606.
   PubMed Web of Science ®Google Scholar
• Ferreira LF, Reid MB. Muscle-derived ROS and thiol regulation in muscle fatigue. J Appl Physiol. 2008;104:853–860.
   PubMed Web of Science ®Google Scholar
• Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, et al. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest. 1994;94:79–88.
   PubMed Web of Science ®Google Scholar
• Macmillan-Crow LA, Cruthirds DL. Invited review: manganese superoxide dismutase in disease. Free Radic Res. 2001;34:325–336.
   PubMed Web of Science ®Google Scholar